Influence of glycoprotein IIb/IIIa inhibitors on bleeding events after successful resuscitation and percutaneous coronary intervention

被引：0
|
作者：
Paul Marc Biever
Dawid Leander Staudacher
Jonas Degott
Corinna Nadine Lang
Christoph Bode
Tobias Wengenmayer
机构：
[1] University of Freiburg,Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center Freiburg University
[2] University of Freiburg,Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine
来源：
Clinical Research in Cardiology | 2020年 / 109卷
关键词：
Glycoprotein IIb/IIIa antagonists; Glycoprotein IIb/IIIa inhibitors; Anticoagulation; Bleeding; Cardiac arrest; Resuscitation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：385 / 392
页数：7
相关论文
共 50 条
  • [1] Influence of glycoprotein IIb/IIIa inhibitors on bleeding events after successful resuscitation and percutaneous coronary intervention
    Biever, Paul Marc
    Staudacher, Dawid Leander
    Degott, Jonas
    Lang, Corinna Nadine
    Bode, Christoph
    Wengenmayer, Tobias
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (03) : 385 - 392
  • [2] Safety of switching glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention
    Grabarczyk, MA
    Staton, S
    Applegate, RJ
    Sacrinty, M
    Baki, TT
    Gandhi, SK
    Little, WC
    Kutcher, MA
    Sane, DC
    Forest, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 37A - 37A
  • [3] Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome
    Crouch, MA
    Nappi, JM
    Cheang, KI
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (06) : 860 - 875
  • [4] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [5] Glycoprotein IIb/IIIa inhibitor therapy and outcomes after percutaneous coronary intervention
    Tepper, RI
    Simonian, N
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06): : 771 - 772
  • [6] Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
    Yerasi, Charan
    Case, Brian C.
    Chezar-Azerrad, Chava
    Forrestal, Brian J.
    Medranda, Giorgio A.
    Shea, Corey
    Zhang, Cheng
    Ben-Dor, Itsik
    Satler, Lowell F.
    Bernardo, Nelson L.
    Hashim, Hayder
    Garcia-Garcia, Hector M.
    Waksman, Ron
    AMERICAN HEART JOURNAL, 2021, 238 : 59 - 65
  • [7] Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary intervention
    Cheng, JWM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (21) : S5 - S14
  • [8] Glycoprotein IIb/IIIa Inhibitors in Patients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention
    Anderson, Joe R.
    Riding, Dan
    CARDIOLOGY IN REVIEW, 2008, 16 (04) : 213 - 218
  • [9] Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
    Vaduganathan, Muthiah
    Harrington, Robert A.
    Stone, Gregg W.
    Deliargyris, Efthymios N.
    Steg, Ph. Gabriel
    Gibson, C. Michael
    Hamm, Christian W.
    Price, Matthew J.
    Menozzi, Alberto
    Prats, Jayne
    Elkin, Steven
    Mahaffey, Kenneth W.
    White, Harvey D.
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (02) : 176 - 185
  • [10] TRANSRADIAL APPROACH IS ASSOCIATED WITH LOWER BLEEDING COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH GLYCOPROTEIN IIB/IIIA INHIBITORS
    Kerner, Arthur
    Abergel, Eitan
    Berger, Michael
    Halabi, Majdi
    Boulus, Monther
    Beyar, Raphael
    Roguin, Ariel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
12345